For this study, researchers recruited 124 people at risk of developing rheumatoid arthritis, seven people who had recently ...

Use of an implantable vagus nerve stimulation device was safe and effective for treating RA among patients who previously failed treatment with at least 1 b/tsDMARD.

Changes in the gut microbiome before rheumatoid arthritis is developed could provide a window of opportunity for preventative treatments, new research suggests.

Rheumatoid arthritis is a common disease affecting an estimated 17 million people worldwide. The disease is caused by immune cells attacking the joints and can result in pain, swelling, and damage to ...

Augurex Life Sciences Corp., a leader in autoimmune biomarker-based diagnostics, today announced that it has formed a nonexclusive agreement with Quest Diagnostics, a leading provider of diagnostic ...

Findings indicate gut microbiome diversity changes precede rheumatoid arthritis, offering insights into microbial indicators ...

Researchers employed analysis tools and machine learning algorithms to identify two genes linked to rheumatoid arthritis and osteoporosis that could serve as diagnostic tools and potential targets for ...

Rheumatoid arthritis is a chronic (persistent) autoimmune condition in which there is inflammation, and therefore, pain in ...

A number of diseases mimic the symptoms of rheumatoid arthritis (RA), an autoimmune form of arthritis. These include ...

University of Leeds-led research has identified specific changes in the gut microbiome of individuals at risk of rheumatoid arthritis, potentially discovering disease onset mechanisms.

Changes in the gut microbiome before rheumatoid arthritis is developed could provide a window of opportunity for preventative treatments, new research suggests.

Researchers say new research findings might point to a major opportunity to act sooner to prevent rheumatoid arthritis.